Yi L. Hwa

6.3k total citations
64 papers, 1.4k citations indexed

About

Yi L. Hwa is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Yi L. Hwa has authored 64 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Hematology, 37 papers in Molecular Biology and 22 papers in Oncology. Recurrent topics in Yi L. Hwa's work include Multiple Myeloma Research and Treatments (34 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (18 papers) and Protein Degradation and Inhibitors (13 papers). Yi L. Hwa is often cited by papers focused on Multiple Myeloma Research and Treatments (34 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (18 papers) and Protein Degradation and Inhibitors (13 papers). Yi L. Hwa collaborates with scholars based in United States, China and Italy. Yi L. Hwa's co-authors include Jin‐Ping Li, Francis K. Buadi, S. Vincent Rajkumar, Shaji Kumar, Prashant Kapoor, Morie A. Gertz, Angela Dispenzieri, Martha Q. Lacy, Sean C. Dowdy and Suzanne R. Hayman and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Yi L. Hwa

61 papers receiving 1.4k citations

Peers

Countries citing papers authored by Yi L. Hwa

Since Specialization

Citations

This map shows the geographic impact of Yi L. Hwa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi L. Hwa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi L. Hwa more than expected).

Fields of papers citing papers by Yi L. Hwa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi L. Hwa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi L. Hwa. The network helps show where Yi L. Hwa may publish in the future.

Co-authorship network of co-authors of Yi L. Hwa

This figure shows the co-authorship network connecting the top 25 collaborators of Yi L. Hwa. A scholar is included among the top collaborators of Yi L. Hwa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi L. Hwa. Yi L. Hwa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Conditional survival in multiple myeloma and impact of prognostic factors over time 2023 ·Blood Cancer Journal ·Nadine Abdallah, Alexandra N. Smith, Susan M. Geyer, Moritz Binder, Patricia T. Greipp, Prashant Kapoor, Angela Dispenzieri, Morie A. Gertz, Linda B. Baughn, Martha Q. Lacy, Suzanne R. Hayman, Francis K. Buadi, David Dingli, Yi L. Hwa, Yi Lin, Taxiarchis Kourelis, Rahma Warsame, Robert A. Kyle, S. Vincent Rajkumar, Shaji Kumar	12
2	The Effect of Duration of Lenalidomide Maintenance and Outcomes of Different Salvage Regimens in Patients with Multiple Myeloma (MM) 2021 ·Blood Cancer Journal ·Matthew Ho, Saurabh Zanwar, Prashant Kapoor, Morie A. Gertz, Martha Q. Lacy, Angela Dispenzieri, Suzanne R. Hayman, David Dingli, (unknown), Eli Muchtar, Nelson Leung, Taxiarchis Kourelis, Rahma Warsame, Amie Fonder, Yi L. Hwa, Miriam Hobbs, Robert A. Kyle, S. Vincent Rajkumar, Shaji Kumar	6
3	Second Stem Cell Transplantation for Relapsed Refractory Light Chain (AL) Amyloidosis 2021 ·Transplantation and Cellular Therapy ·Eli Muchtar, Angela Dispenzieri, Shaji Kumar, Martha Q. Lacy, Francis K. Buadi, David Dingli, Suzanne R. Hayman, Nelson Leung, Prashant Kapoor, Wilson I. Gonsalves, Taxiarchis Kourelis, Rahma Warsame, Yi L. Hwa, Amie Fonder, Miriam Hobbs, Ronald S. Go, S. Vincent Rajkumar, Robert A. Kyle, William J. Hogan, Morie A. Gertz	2
4	Factors Associated with Renal Impairment at Diagnosis in Multiple Myeloma with Survival Trends over Last Two Decades 2021 ·Blood ·Sagar Rakshit, Radhika Bansal, Prashant Kapoor, Angela Dispenzieri, Morie A. Gertz, Martha Q. Lacy, Suzanne R. Hayman, Francis K. Buadi, Yi L. Hwa, Amie Fonder, Miriam Hobbs, Wilson I. Gonsalves, Eli Muchtar, David Dingli, Taxiarchis Kourelis, Rahma Warsame, Robert A. Kyle, S. Vincent Rajkumar, Shaji Kumar, Nelson Leung	0
5	Use of beta blockers is associated with survival outcome of multiple myeloma patients treated with pomalidomide 2020 ·European Journal Of Haematology ·Yi L. Hwa, Martha Q. Lacy, Morie A. Gertz, Shaji Kumar, Eli Muchtar, Francis K. Buadi, David Dingli, Nelson Leung, Prashant Kapoor, Ronald S. Go, Miriam Hobbs, Amie Fonder, Wilson I. Gonsalves, Rahma Warsame, Taxiarchis Kourelis, (unknown), Mustaqeem Siddiqui, S. Vincent Rajkumar, Angela Dispenzieri	2
6	Outcomes with early vs. deferred stem cell transplantation in light chain amyloidosis 2020 ·Bone Marrow Transplantation ·Nadine Abdallah, Surbhi Sidana, Angela Dispenzieri, Martha Q. Lacy, Francis K. Buadi, Suzanne R. Hayman, Prashant Kapoor, Nelson Leung, David Dingli, Yi L. Hwa, John A. Lust, Stephen J. Russell, Wilson I. Gonsalves, Ronald S. Go, William J. Hogan, Robert A. Kyle, S. Vincent Rajkumar, Morie A. Gertz, Shaji Kumar	4
7	The why and how of maintaining hydration during cancer therapy 2020 ·Current Opinion in Supportive and Palliative Care ·Yi L. Hwa, (unknown)	4
8	Substratification of patients with newly diagnosed standard‐risk multiple myeloma 2019 ·British Journal of Haematology ·Moritz Binder, S. Vincent Rajkumar, Rhett P. Ketterling, Angela Dispenzieri, Martha Q. Lacy, Morie A. Gertz, Francis K. Buadi, Suzanne R. Hayman, Yi L. Hwa, Steven R. Zeldenrust, John A. Lust, Stephen J. Russell, Nelson Leung, Prashant Kapoor, Ronald S. Go, Wilson I. Gonsalves, Robert A. Kyle, Shaji Kumar	10
9	Immunoglobulin Light-Chain Amyloidosis: Clinical Presentations and Diagnostic Approach 2019 ·Journal of the Advanced Practitioner in Oncology ·Yi L. Hwa, (unknown), (unknown), Douglas V. Faller, (unknown), (unknown), Lisa Mendelson	8
10	Impact of involved free light chain (FLC) levels in patients achieving normal FLC ratio after initial therapy in light chain amyloidosis (AL) 2017 ·American Journal of Hematology ·Nidhi Tandon, Surbhi Sidana, Angela Dispenzieri, Morie A. Gertz, Martha Q. Lacy, David Dingli, Francis K. Buadi, Amie Fonder, Suzanne R. Hayman, Yi L. Hwa, Miriam Hobbs, Prashant Kapoor, Wilson I. Gonsalves, Nelson Leung, Ronald S. Go, John A. Lust, Stephen J. Russell, Robert A. Kyle, S. Vincent Rajkumar, Shaji Kumar	6
11	Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma 2017 ·Blood Cancer Journal ·Moritz Binder, S. Vincent Rajkumar, Rhett P. Ketterling, Patricia T. Greipp, Angela Dispenzieri, Martha Q. Lacy, Morie A. Gertz, Francis K. Buadi, Suzanne R. Hayman, Yi L. Hwa, Stephen R. Zeldenrust, John A. Lust, Stephen J. Russell, Nelson Leung, Prashant Kapoor, Ronald S. Go, Wilson I. Gonsalves, Robert A. Kyle, Shaji Kumar	56
12	Occurrence and prognostic significance of cytogenetic evolution in patients with multiple myeloma 2016 ·Blood Cancer Journal ·Moritz Binder, S. Vincent Rajkumar, Rhett P. Ketterling, Angela Dispenzieri, Martha Q. Lacy, Morie A. Gertz, Francis K. Buadi, Suzanne R. Hayman, Yi L. Hwa, Stephen R. Zeldenrust, John A. Lust, Stephen J. Russell, Nelson Leung, Prashant Kapoor, Ronald S. Go, Wilson I. Gonsalves, Robert A. Kyle, Shaji Kumar	20
13	Iron Deficiency in Long‐Term Parenteral Nutrition Therapy 2015 ·Journal of Parenteral and Enteral Nutrition ·Yi L. Hwa, Shahrooz Rashtak, Darlene G. Kelly, Joseph A. Murray	23
14	Impact of cytogenetic classification on outcomes following early high-dose therapy in multiple myeloma 2015 ·Leukemia ·(unknown), Morie A. Gertz, Angela Dispenzieri, Martha Q. Lacy, Francis K. Buadi, David Dingli, Suzanne R. Hayman, Prashant Kapoor, John A. Lust, Stephen J. Russell, Ronald S. Go, Yi L. Hwa, Robert A. Kyle, S. Vincent Rajkumar, Shaji Kumar	41
15	Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapy 2015 ·Leukemia ·Muhamad Alhaj Moustafa, S. Vincent Rajkumar, Angela Dispenzieri, Morie A. Gertz, Martha Q. Lacy, Francis K. Buadi, Yi L. Hwa, David Dingli, Prashant Kapoor, Suzanne R. Hayman, John A. Lust, Robert A. Kyle, Shaji Kumar	24
16	Expression of Histone Acetyltransferase GCN5 and Histone Deacetylase 1 in the Cultured Mouse Preimplantation Embryos 2014 ·Current Pharmaceutical Design ·Xiaozhen Liu, (unknown), Yingming Zheng, Liya Wang, Yuli Qian, Chenming Xu, (unknown), Yi L. Hwa, Fan Jin	4
17	Therapeutic Strategies For Initial Treatment Of AL Amyloidosis: Implications Of Therapy and Response On Outcome 2013 ·Blood ·Angela Dispenzieri, Morie A. Gertz, (unknown), Martha Q. Lacy, Francis K. Buadi, Suzanne R. Hayman, Nelson Leung, Arleigh McCurdy, Yi L. Hwa, (unknown), David Dingli, Prashant Kapoor, Steven R. Zeldenrust, John A. Lust, Stephen J. Russell, S. Vincent Rajkumar, Shaji Kumar	2
18	DNA hypermethylation as a chemotherapy target 2011 ·Cellular Signalling ·Juan Ren, Brahma N. Singh, Qiang Huang, Zongfang Li, Ya Gao, Prachi Mishra, Yi L. Hwa, Jin‐Ping Li, Sean C. Dowdy, Shi-Wen Jiang	79
19	Tumor markers for early detection of ovarian cancer 2010 ·Expert Review of Molecular Diagnostics ·Juan Ren, Hui Cai, Yi Li, (unknown), Zi Liu, Jiansheng Wang, Yi L. Hwa, Yuelang Zhang, Ya Yang, Yu Li, Shi‐Wen Jiang	24
20	Primary adenomyoepithelioma of tonsil 2010 ·Head & Neck Oncology ·Juan Ren, Liping Song, Qiang Dang, Xiaozhi Zhang, Shi‐Wen Jiang, Guanjun Zhang, Ning Wang, (unknown), Jiansheng Wang, Yi L. Hwa, Zongfang Li, Xinhan Zhao, Yuan Liu	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact